Copyright Reports & Markets. All rights reserved.

Global Fusion Spine Surgery Biomaterials Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Fusion Spine Surgery Biomaterials
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Fusion Spine Surgery Biomaterials by Type
    • 1.3.1 Overview: Global Fusion Spine Surgery Biomaterials Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Fusion Spine Surgery Biomaterials Consumption Value Market Share by Type in 2022
    • 1.3.3 Bone Graft
    • 1.3.4 Bone Graft Substitute
    • 1.3.5 Platelet Rich Plasma (PRP)
    • 1.3.6 Other
  • 1.4 Global Fusion Spine Surgery Biomaterials Market by Application
    • 1.4.1 Overview: Global Fusion Spine Surgery Biomaterials Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Open Surgery
    • 1.4.3 Minimally Invasive Surgery
  • 1.5 Global Fusion Spine Surgery Biomaterials Market Size & Forecast
  • 1.6 Global Fusion Spine Surgery Biomaterials Market Size and Forecast by Region
    • 1.6.1 Global Fusion Spine Surgery Biomaterials Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Fusion Spine Surgery Biomaterials Market Size by Region, (2018-2029)
    • 1.6.3 North America Fusion Spine Surgery Biomaterials Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Fusion Spine Surgery Biomaterials Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Fusion Spine Surgery Biomaterials Market Size and Prospect (2018-2029)
    • 1.6.6 South America Fusion Spine Surgery Biomaterials Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Fusion Spine Surgery Biomaterials Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Medtronic
    • 2.1.1 Medtronic Details
    • 2.1.2 Medtronic Major Business
    • 2.1.3 Medtronic Fusion Spine Surgery Biomaterials Product and Solutions
    • 2.1.4 Medtronic Fusion Spine Surgery Biomaterials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Medtronic Recent Developments and Future Plans
  • 2.2 J & J
    • 2.2.1 J & J Details
    • 2.2.2 J & J Major Business
    • 2.2.3 J & J Fusion Spine Surgery Biomaterials Product and Solutions
    • 2.2.4 J & J Fusion Spine Surgery Biomaterials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 J & J Recent Developments and Future Plans
  • 2.3 Stryker Corporation
    • 2.3.1 Stryker Corporation Details
    • 2.3.2 Stryker Corporation Major Business
    • 2.3.3 Stryker Corporation Fusion Spine Surgery Biomaterials Product and Solutions
    • 2.3.4 Stryker Corporation Fusion Spine Surgery Biomaterials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Stryker Corporation Recent Developments and Future Plans
  • 2.4 Nuvasive
    • 2.4.1 Nuvasive Details
    • 2.4.2 Nuvasive Major Business
    • 2.4.3 Nuvasive Fusion Spine Surgery Biomaterials Product and Solutions
    • 2.4.4 Nuvasive Fusion Spine Surgery Biomaterials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Nuvasive Recent Developments and Future Plans
  • 2.5 Zimmer Biomet
    • 2.5.1 Zimmer Biomet Details
    • 2.5.2 Zimmer Biomet Major Business
    • 2.5.3 Zimmer Biomet Fusion Spine Surgery Biomaterials Product and Solutions
    • 2.5.4 Zimmer Biomet Fusion Spine Surgery Biomaterials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Zimmer Biomet Recent Developments and Future Plans
  • 2.6 Orthofix International
    • 2.6.1 Orthofix International Details
    • 2.6.2 Orthofix International Major Business
    • 2.6.3 Orthofix International Fusion Spine Surgery Biomaterials Product and Solutions
    • 2.6.4 Orthofix International Fusion Spine Surgery Biomaterials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Orthofix International Recent Developments and Future Plans
  • 2.7 Globus Medical
    • 2.7.1 Globus Medical Details
    • 2.7.2 Globus Medical Major Business
    • 2.7.3 Globus Medical Fusion Spine Surgery Biomaterials Product and Solutions
    • 2.7.4 Globus Medical Fusion Spine Surgery Biomaterials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Globus Medical Recent Developments and Future Plans
  • 2.8 alphatec spine
    • 2.8.1 alphatec spine Details
    • 2.8.2 alphatec spine Major Business
    • 2.8.3 alphatec spine Fusion Spine Surgery Biomaterials Product and Solutions
    • 2.8.4 alphatec spine Fusion Spine Surgery Biomaterials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 alphatec spine Recent Developments and Future Plans
  • 2.9 K2M
    • 2.9.1 K2M Details
    • 2.9.2 K2M Major Business
    • 2.9.3 K2M Fusion Spine Surgery Biomaterials Product and Solutions
    • 2.9.4 K2M Fusion Spine Surgery Biomaterials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 K2M Recent Developments and Future Plans
  • 2.10 Exactech
    • 2.10.1 Exactech Details
    • 2.10.2 Exactech Major Business
    • 2.10.3 Exactech Fusion Spine Surgery Biomaterials Product and Solutions
    • 2.10.4 Exactech Fusion Spine Surgery Biomaterials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Exactech Recent Developments and Future Plans
  • 2.11 Wright Medical Technology
    • 2.11.1 Wright Medical Technology Details
    • 2.11.2 Wright Medical Technology Major Business
    • 2.11.3 Wright Medical Technology Fusion Spine Surgery Biomaterials Product and Solutions
    • 2.11.4 Wright Medical Technology Fusion Spine Surgery Biomaterials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Wright Medical Technology Recent Developments and Future Plans
  • 2.12 X-Spine
    • 2.12.1 X-Spine Details
    • 2.12.2 X-Spine Major Business
    • 2.12.3 X-Spine Fusion Spine Surgery Biomaterials Product and Solutions
    • 2.12.4 X-Spine Fusion Spine Surgery Biomaterials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 X-Spine Recent Developments and Future Plans
  • 2.13 Nutech
    • 2.13.1 Nutech Details
    • 2.13.2 Nutech Major Business
    • 2.13.3 Nutech Fusion Spine Surgery Biomaterials Product and Solutions
    • 2.13.4 Nutech Fusion Spine Surgery Biomaterials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Nutech Recent Developments and Future Plans
  • 2.14 Arthrex
    • 2.14.1 Arthrex Details
    • 2.14.2 Arthrex Major Business
    • 2.14.3 Arthrex Fusion Spine Surgery Biomaterials Product and Solutions
    • 2.14.4 Arthrex Fusion Spine Surgery Biomaterials Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Arthrex Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Fusion Spine Surgery Biomaterials Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Fusion Spine Surgery Biomaterials by Company Revenue
    • 3.2.2 Top 3 Fusion Spine Surgery Biomaterials Players Market Share in 2022
    • 3.2.3 Top 6 Fusion Spine Surgery Biomaterials Players Market Share in 2022
  • 3.3 Fusion Spine Surgery Biomaterials Market: Overall Company Footprint Analysis
    • 3.3.1 Fusion Spine Surgery Biomaterials Market: Region Footprint
    • 3.3.2 Fusion Spine Surgery Biomaterials Market: Company Product Type Footprint
    • 3.3.3 Fusion Spine Surgery Biomaterials Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Fusion Spine Surgery Biomaterials Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Fusion Spine Surgery Biomaterials Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Fusion Spine Surgery Biomaterials Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Fusion Spine Surgery Biomaterials Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Fusion Spine Surgery Biomaterials Consumption Value by Type (2018-2029)
  • 6.2 North America Fusion Spine Surgery Biomaterials Consumption Value by Application (2018-2029)
  • 6.3 North America Fusion Spine Surgery Biomaterials Market Size by Country
    • 6.3.1 North America Fusion Spine Surgery Biomaterials Consumption Value by Country (2018-2029)
    • 6.3.2 United States Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Fusion Spine Surgery Biomaterials Consumption Value by Type (2018-2029)
  • 7.2 Europe Fusion Spine Surgery Biomaterials Consumption Value by Application (2018-2029)
  • 7.3 Europe Fusion Spine Surgery Biomaterials Market Size by Country
    • 7.3.1 Europe Fusion Spine Surgery Biomaterials Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)
    • 7.3.3 France Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Fusion Spine Surgery Biomaterials Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Fusion Spine Surgery Biomaterials Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Fusion Spine Surgery Biomaterials Market Size by Region
    • 8.3.1 Asia-Pacific Fusion Spine Surgery Biomaterials Consumption Value by Region (2018-2029)
    • 8.3.2 China Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)
    • 8.3.5 India Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Fusion Spine Surgery Biomaterials Consumption Value by Type (2018-2029)
  • 9.2 South America Fusion Spine Surgery Biomaterials Consumption Value by Application (2018-2029)
  • 9.3 South America Fusion Spine Surgery Biomaterials Market Size by Country
    • 9.3.1 South America Fusion Spine Surgery Biomaterials Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Fusion Spine Surgery Biomaterials Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Fusion Spine Surgery Biomaterials Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Fusion Spine Surgery Biomaterials Market Size by Country
    • 10.3.1 Middle East & Africa Fusion Spine Surgery Biomaterials Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Fusion Spine Surgery Biomaterials Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Fusion Spine Surgery Biomaterials Market Drivers
  • 11.2 Fusion Spine Surgery Biomaterials Market Restraints
  • 11.3 Fusion Spine Surgery Biomaterials Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Fusion Spine Surgery Biomaterials Industry Chain
  • 12.2 Fusion Spine Surgery Biomaterials Upstream Analysis
  • 12.3 Fusion Spine Surgery Biomaterials Midstream Analysis
  • 12.4 Fusion Spine Surgery Biomaterials Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Fusion Spine Surgery Biomaterials market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Fusion spine surgery remains one of the most performed instrumented spinal surgeries. Using bone graft substitutes as an alternative to autologous bone has become widely accepted.
    This report is a detailed and comprehensive analysis for global Fusion Spine Surgery Biomaterials market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Fusion Spine Surgery Biomaterials market size and forecasts, in consumption value ($ Million), 2018-2029
    Global Fusion Spine Surgery Biomaterials market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
    Global Fusion Spine Surgery Biomaterials market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
    Global Fusion Spine Surgery Biomaterials market shares of main players, in revenue ($ Million), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Fusion Spine Surgery Biomaterials
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Fusion Spine Surgery Biomaterials market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, J & J, Stryker Corporation, Nuvasive and Zimmer Biomet, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market segmentation
    Fusion Spine Surgery Biomaterials market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Bone Graft
    Bone Graft Substitute
    Platelet Rich Plasma (PRP)
    Other
    Market segment by Application
    Open Surgery
    Minimally Invasive Surgery
    Market segment by players, this report covers
    Medtronic
    J & J
    Stryker Corporation
    Nuvasive
    Zimmer Biomet
    Orthofix International
    Globus Medical
    alphatec spine
    K2M
    Exactech
    Wright Medical Technology
    X-Spine
    Nutech
    Arthrex
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Fusion Spine Surgery Biomaterials product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Fusion Spine Surgery Biomaterials, with revenue, gross margin and global market share of Fusion Spine Surgery Biomaterials from 2018 to 2023.
    Chapter 3, the Fusion Spine Surgery Biomaterials competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Fusion Spine Surgery Biomaterials market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
    Chapter 12, the key raw materials and key suppliers, and industry chain of Fusion Spine Surgery Biomaterials.
    Chapter 13, to describe Fusion Spine Surgery Biomaterials research findings and conclusion.

    Buy now